The alternative sigma factor B of Staphylococcus aureus controls the expression of multiple genes, including virulence determinants and global regulators; promotes capsule production; and increases the resistance levels of methicillin-resistant S. aureus (MRSA) and glycopeptide-intermediate-resistant S. aureus (GISA) strains. We show here that deletion of the B -controlled yabJ-spoVG operon, which codes for potential downstream regulators of B , abolished capsule synthesis and reduced resistance in MRSA and GISA to the same extent that B inactivation did. Introduction of the yabJ-spoVG operon in trans restored the original phenotype. By genetic manipulations, we show that SpoVG but not YabJ is required for complementation. We therefore postulate that SpoVG is the major factor of the yabJ-spoVG operon required in S. aureus for capsule formation and antibiotic resistance.A large set of virulence factors allows Staphylococcus aureus to cause a wide spectrum of diseases, which range from superficial to life-threatening infections (26). The production of the virulence determinants is tightly controlled by a network of global regulators, including the alternative transcription factor B (for reviews, see references 8 and 30). Besides its role in the general stress response (7,12,13,19,24,25), B affects methicillin and glycopeptide resistance (2,28,34,39,40), pigment production (13,21,25,28,32), internalization into endothelial cells (29), S. aureus-induced apoptosis (16), and capsule formation (27) and modulates the expression of a variety of virulence factors and regulatory elements (for a review, see reference 3). Recent microarray analyses showed that B affects the expression of a large number of genes/operons (3, 33). However, a surprisingly large fraction of these genes/operons are not preceded by an apparent B promoter (18), including e.g., the cap operon, which codes for capsular polysaccharide production (for a review, see reference 31), and fnbA, which codes for fibronectin binding protein A. This indicates that downstream-acting regulators mediating the effect of the alternative transcription factor B should exist. The way B exerts its impact on the resistance to cell wall antibiotics and capsule formation as well as the postulated B effectors remain unknown. We recently showed that inactivation of the staphylococcal B -controlled yabJ-spoVG operon, which codes for Bacillus subtilis YabJ and SpoVG sequence homologs, significantly reduces the level of transcription of the cap operon and impedes capsule formation in capsular polysaccharide-producing strain Newman (27), suggesting that products of the yabJ-spoVG locus might serve as B effectors that modulate B -dependent genes lacking an apparent B promoter. In this study, we deleted the yabJ-spoVG operon and analyzed its effect on the resistance levels of methicillin-resistant S. aureus (MRSA) and glycopeptide-intermediate-resistant S. aureus (GISA) strains. We present here data showing that the deletion of the yabJ-spoVG operon decreases resistance in MRSA and...